Is Infrequent Serum Hormone Testing Failing Peri- & Menopause Care? A Real-Time, Case-Based Guide
Dr. Carrie Jones (ND, FABNE, MPH, MSCP) and Rose MacKenzie (Clinical Manager at Mira) join Dr. Kara Fitzgerald for a practical, case-based exploration of real-time hormone testing in perimenopause and menopause care. Traditional hormone testing often captures a single snapshot, missing the dynamic fluctuations that define the menopause transition. In this clinician-focused webinar, we’ll show how longitudinal, at-home hormone data can sharpen diagnostics, guide HRT decisions, and improve treatment monitoring. Using real patient cases and cycle charts, this session will walk through how continuous hormone insights can change clinical decision-making in practice. We’ll cover:
How real-time hormone testing supports diagnosis and treatment monitoring (step-by-step)
How Mira complements blood, DUTCH, and other conventional hormone tests
How different HRT strategies shape hormone patterns over time
New research on FSH as a risk marker during the menopause transition
How clinicians are monitoring FSH suppression and hormone trends longitudinally to guide care
Register today to join this data-driven, practical conversation designed for clinicians who want more precision, less guesswork, and better outcomes in peri- and menopause care.
Live attendees will have the opportunity to participate in an interactive Q&A session.
A limited-time replay will be available exclusively to registrants. *This event is for informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider.